Get access to our best features
Get access to our best features
Published 2 years ago

'Historic moment' in Alzheimer's treatment as trial drug found to slow cognitive decline

Summary by Financial Post
An experimental Alzheimer's drug developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, the companies said on Tuesday.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 62% of the sources are Center
62% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)